Divi's Laboratories Reports Major Milestones in Sustainability Amid Robust Operations

Divi's Laboratories Reports Major Milestones in Sustainability Amid Robust Operations​

Divi's Laboratories Limited has released its Business Responsibility and Sustainability Report (BRSR) for the financial year 2025-26, detailing extensive operational achievements across environmental stewardship, resource conservation, and workforce well-being. The report underscores the company’s commitment to sustainable manufacturing while maintaining high standards in the production of Active Pharmaceutical Ingredients (APIs), Intermediates, and Nutraceuticals.

The company operates with four plants and one office nationally, supported by two international offices. Divi's serves markets across 23 Indian states and 80 countries, with exports contributing 89% of the total turnover. The entity reported a paid-up capital of 53,09,37,160/- and demonstrated strong financial health with a net worth of 16,711 crore.

Environmental Stewardship and Resource Management​

A key focus of the FY 2025-26 reporting period was environmental mitigation and resource efficiency. The company successfully implemented various initiatives to reduce Greenhouse Gas (GHG) emissions, achieving a reduction of approximately 13,500 TCO 2 e GHG emissions.

Resource conservation efforts were also highlighted, with an achievement of approximately 1,59,500 KL of water conserved and roughly 8,290 GJ of energy conserved through operational improvements. Divi's Laboratories is committed to long-term sustainable targets and has received approval from the Science Based Targets initiative (SBTi) for both Near Term and Net Zero GHG emissions.

The company has established dedicated waste management practices. For FY 2025-26, the entity reduced plastic packaging waste by approximately 46 MT. Waste streams are managed through compliant procedures, with hazardous waste sent for co-processing or to authorized Treatment, Storage and Disposal Facilities (TSDFs).

Key environmental performance metrics:

Governance and Workforce Practices​

The report details the commitment to ethical operations and workforce welfare. The company operates under a Risk Management and Sustainability Committee, which oversees all Environmental, Social, and Governance (ESG) related topics. Dr. S. Devendra Rao, Whole-time Director (Manufacturing), is detailed as the highest authority responsible for the implementation and oversight of the Business Responsibility policy.

The organization employs 12,119 employees across permanent and non-permanent categories, and 7,173 workers. The company demonstrates a commitment to continuous training and professional growth:

• Employees: All 11,514 permanent employees received training on Health and Safety measures, maintaining a 100% coverage rate.
• Workforce: Both the physical safety of and skill upgradation training were completed for all workers (100% coverage).

Divi's Laboratories maintains a framework for human rights by stating that grievances related to unethical behavior or fraud can be reported through the Whistle Blower Policy, which reports concerns to the Vigilance Officer or the Chairman of the Audit Committee. Furthermore, the company confirms its commitment to providing fair wages across all employee categories, with data showing employees receiving gross wages equal to 9.20% of total wages in FY 2025-26.

Industry and Consumer Relations​

The company's business model is fundamentally B2B (Business-to-business), serving a concentrated group of large customers. Procedures are in place to receive customer complaints, which include established timelines for resolution. The report confirms that the company's products and services meet required standards regarding safety and responsible usage, with no consumer complaints reported across key categories such as data privacy or unfair trade practices.

Divi's Laboratories Limited has maintained rigorous oversight of its supply chain, noting that 54.52% of supply chain partners have responded to participate in assessments concerning health and safety practices. This focus on continuous improvement across the entire value chain reinforces the company's commitment to sustainable growth and ethical conduct within the pharmaceutical ingredients sector.

DIVISLAB Stock Price Movement​

Divi's Laboratories Limited closed higher today, as shares climbed by 1.55% and settled at ₹7273. The stock gained ₹111.50 after testing a 52-week high of ₹7330 during the day, with trading volume reaching 726,479 shares.